Better, Stronger, Faster: Why Nootropics Will Be Big Business In 2016
Originally published in Forbes By Mike Montgomery Depending on whose numbers you believe, the U.S. supplement industry is either a $12 billion or a $37 billion industry. That’s…
Originally published in Forbes By Mike Montgomery Depending on whose numbers you believe, the U.S. supplement industry is either a $12 billion or a $37 billion industry. That’s…
Originally published in The Street By Douglas Fink In 2016, crowd financing will become big business for small- and medium-sized companies. But tech-start-up unicorns? Not so…
Originally published in Huffington Post By Florence Comite, MD The phrase “Brave New World” has become one of the most often used clichés in medical technology in…
Originally published in CNBC By Phil Wickham, CEO of Kauffman Fellows For most people, a unicorn is a mythical horse with a pointed horn in a…
By Dave Maney, Founder and CEO of Deke Digital The most important decision a chief executive makes is picking their second-in-command. And in a role often…
Originally published in CNN by Ramphis Castro A recent event at Havana’s Panorama Hotel provided a unique view into the future of Cuba. Some 50…
Originally published in The Street By Douglas Fink On Halloween, the SEC finalized long-awaited rules that will allow non-accredited investors to buy shares of privately held companies…
Originally published in Entrepreneur By Jonathon Triest Somewhere in that slush pile of pitches on my desk is an original idea and a bio of an…
Originally published in The Street By Thomas Stoner Jr. Many investors lump all their energy investments together, including everything from oil and gas exploration to solar energy….
Originally published on PE Hub By Phil Wickham, Kauffman Fellows Venture capitalists, like the entrepreneurs they finance, never sleep. They are always searching, moving, evolving. The…